Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hlusí

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Vnitrni Lekarstvi|April 22, 2009
[Molecular methods in thrombophilic states diagnostics]L Slavík, V Krcová, A Hlusí, et al.
Vnitrni Lekarstvi|August 5, 2010
[Essential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin. A report from the database of register for the 1st quarter of 2010]M Penka, J Schwarz, P Ovesná, et al.
Vnitrni Lekarstvi|April 16, 2002
[Importance of determination of serum beta-2-microglobulin levels in patients with Hodgkin's lymphoma]L Raida, T Papajík, A Hlusí, et al.
Vnitrni Lekarstvi|November 6, 2001
[Comparison of the effectiveness of idarubicin (Zavedos) and mitoxantrone (Refador) in induction therapy of acute myeloid leukemia in elderly patients (55-75) (a prospective multicenter randomized study conducted 1998-2000]K Indrák, J Hubácek, J Mayer, et al.
Vnitrni Lekarstvi|December 19, 2009
[The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin]M Penka, J Schwarz, T Pavlík, et al.
Vnitrni Lekarstvi|June 15, 2006
[Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR]M Penka, M Doubek, J Schwarz, et al.
Vnitrni Lekarstvi|August 19, 2007
[Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006]M Penka, J Schwarz, T Pavlík, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Vnitrni Lekarstvi|April 22, 2009
[Molecular methods in thrombophilic states diagnostics]L Slavík, V Krcová, A Hlusí, et al.
Vnitrni Lekarstvi|August 5, 2010
[Essential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin. A report from the database of register for the 1st quarter of 2010]M Penka, J Schwarz, P Ovesná, et al.
Vnitrni Lekarstvi|April 16, 2002
[Importance of determination of serum beta-2-microglobulin levels in patients with Hodgkin's lymphoma]L Raida, T Papajík, A Hlusí, et al.
Vnitrni Lekarstvi|November 6, 2001
[Comparison of the effectiveness of idarubicin (Zavedos) and mitoxantrone (Refador) in induction therapy of acute myeloid leukemia in elderly patients (55-75) (a prospective multicenter randomized study conducted 1998-2000]K Indrák, J Hubácek, J Mayer, et al.
Vnitrni Lekarstvi|December 19, 2009
[The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin]M Penka, J Schwarz, T Pavlík, et al.
Vnitrni Lekarstvi|June 15, 2006
[Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR]M Penka, M Doubek, J Schwarz, et al.
Vnitrni Lekarstvi|August 19, 2007
[Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006]M Penka, J Schwarz, T Pavlík, et al.
Pageof 1